On 24-25 January 2017, the World Health Organization held an informal consultation in Geneva, Switzerland, to review the list of priority diseases for the WHO R&D Blueprint.
The January 2017 meeting brought together virologists, bacteriologists, vaccinologists, public and animal health professionals as well as infectious disease clinicians to review the list of priority diseases. These experts made use of a tailored prioritization methodology developed by WHO and validated at an informal consultation in November 2016. The methodology uses the Delphi technique, questionnaires, multi-criteria decision analysis, and expert review to identify relevant diseases.